Elevance Health director granted 563 deferred units

Elevance Health director Ryan M. Schneider received an equity grant of 563 deferred stock units of common stock as board compensation.

Rhea-AI Filing Summary

Elevance Health director Ryan M. Schneider received an equity grant of 563 deferred stock units of common stock as board compensation. The units were awarded at no cash cost and increase his directly held equity to 7,163 shares. These deferred stock units are scheduled to be settled in Elevance Health common stock on the earlier of five years from the grant date or when he leaves the board, unless he has elected a later distribution date under the company’s Board of Directors Deferred Compensation Plan. This is a routine, compensation-related acquisition rather than an open-market purchase.

Insider Trade Summary

Grant/Award: 563 shares

Grant/Award 1 txn

Insider Schneider Ryan M.

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	563	$0.00	$0.00

Holdings After Transaction: Common Stock — 7,163 shares (Direct)

Footnotes (2)

1. F1. Deferred stock units accrued under the Elevance Health, Inc. ("Company") Board of Directors Compensation Program.
2. F2. The deferred stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan.

Key Figures

Deferred stock units granted: 563 units Price per unit: $0.0000 per unit Shares held after grant: 7,163 shares +1 more

4 metrics

Deferred stock units granted 563 units Equity award to director Ryan M. Schneider

Price per unit $0.0000 per unit Reported grant price for deferred stock units

Shares held after grant 7,163 shares Total directly held Elevance Health common stock after transaction

Payout horizon 5 years Deferred units payable five years from grant or upon board departure

Key Terms

Deferred stock units, Board of Directors Compensation Program, Board of Directors Deferred Compensation Plan

3 terms

Deferred stock units financial

"Deferred stock units accrued under the Elevance Health, Inc. Board of Directors Compensation Program."

Deferred stock units are promises from a company to give an employee shares of stock at a future date, often after certain conditions are met or after leaving the company. They function like a form of delayed compensation, allowing employees to earn shares over time. For investors, they represent potential future ownership in the company, but do not provide immediate voting rights or dividends until the shares are actually received.

Board of Directors Compensation Program financial

"Deferred stock units accrued under the Elevance Health, Inc. Board of Directors Compensation Program."

Board of Directors Deferred Compensation Plan financial

"Election made under the Company's Board of Directors Deferred Compensation Plan."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Elevance Health (ELV) director Ryan Schneider report?

Ryan M. Schneider reported receiving 563 deferred stock units of Elevance Health common stock as board compensation. These units were granted at no cash cost and increase his directly held equity position to 7,163 shares following the award.

Was the Elevance Health (ELV) Form 4 transaction an open-market stock purchase?

No, the Form 4 shows a grant of 563 deferred stock units, not an open-market purchase. The award is classified as a compensation-related grant or other acquisition, with a reported price per unit of $0.0000.

How many Elevance Health (ELV) shares does Ryan Schneider hold after this grant?

After receiving 563 deferred stock units, Ryan M. Schneider is reported as directly holding 7,163 shares of Elevance Health common stock. This total reflects his position immediately following the compensation-related equity award reported in the Form 4.

When will Ryan Schneider’s Elevance Health (ELV) deferred stock units be paid out?

The deferred stock units are payable in Elevance Health common stock on the earlier of five years from the grant date or when he leaves the board, unless he has elected a later payment date under the company’s Board of Directors Deferred Compensation Plan.

What program governs the deferred stock units granted to Elevance Health (ELV) director Ryan Schneider?

The deferred stock units were accrued under Elevance Health’s Board of Directors Compensation Program. Their payout timing can be affected by elections made under the company’s Board of Directors Deferred Compensation Plan, which allows directors to defer receipt of shares to a later date.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/15/2026 - 04:15 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Schneider Ryan M.

(Last) (First) (Middle)

220 VIRGINIA AVENUE

(Street)

INDIANAPOLIS INDIANA 46204

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Elevance Health, Inc. [ ELV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/13/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/13/2026		A		563(1)(2)	A	$0	7,163	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Deferred stock units accrued under the Elevance Health, Inc. ("Company") Board of Directors Compensation Program.

2. The deferred stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan.

Remarks:

	/s/ Kathleen S. Kiefer, Attorney in fact	05/15/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)